AR
Aryzta AG
ARZTY · OTC
$4.72 +0.00% (+$0.00)
1M -7.63%
Market Cap 1.08B €
P/E Ratio 10.03x
Div. Yield -
ROE 22.66%
Bulios Fair Price
$5.33
12.9% upside
Current Price
$4.72
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ARZTY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
100 /100
Cheap P/E 10.03x
EV/EBITDA 5.88x
P/S 0.51x
Growth
80 /100
Growing Rev. growth 6.74%
FCF growth 12.28%
Book val. growth 15.99%
Profitability
50 /100
Moderate Gross margin 31.62%
Net margin 5.05%
Op. margin 7.76%
Quality
74 /100
Excellent ROIC 9.96%
ROE 22.66%
ROA 5.71%
Debt
33 /100
High Debt/Equity 1.29x
Current ratio 0.58x
Int. coverage 3.53x
Stability
50 /100
Moderate Beta 0.35x
Rev. volatility 12.25%
EPS volatility 2,225.67%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ARZTY
Online
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Urs Jordi
Employees
7,654
Headquarters
Schlieren